Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05667649
PHASE1

Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease

Sponsor: Regeneration Biomedical, Inc.

View on ClinicalTrials.gov

Summary

This is a research study to evaluate the safety of an investigational autologous cell product obtained from participant's own adipose tissue as a possible treatment for Alzheimer disease.

Official title: Ph 1, Open-Label Safety Study of Escalating Doses of Intracerebroventricular Injections of Ex Vivo Expanded, Autologous ADSCs in Participants With Mild-Moderate AD Whose Treatment is Not Addressed Adequately by Available Therapy

Key Details

Gender

All

Age Range

45 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

18

Start Date

2023-08-14

Completion Date

2026-08

Last Updated

2025-04-04

Healthy Volunteers

No

Interventions

BIOLOGICAL

RB-ADSC

Ex Vivo Expanded, Autologous Adipose-Derived Stem Cells (ADSCs)

Locations (1)

Hoag Memorial Hospital Presbyterian

Newport Beach, California, United States